Inactive Instrument

Iomai Corporation Share Price

Stocks

US46202P1030

Pharmaceuticals

End-of-day quote Nasdaq
- - Intraday chart for Iomai Corporation
Manager TitleAgeSince
Corporate Officer/Principal 59 30/11/2015
Director of Finance/CFO 56 -
Corporate Officer/Principal - 31/07/2008
Director TitleAgeSince
Director/Board Member 87 04/07/2006
Director/Board Member 83 31/12/2005
Director/Board Member 73 31/12/2001
Change 5-day change 1-year change 3-year change Capi.($)
-0.51%+1.57%+17.05%-7.30% 67.61B
-5.16%-8.63%+38.70%+203.59% 51.6B
+5.28%+39.50%+39.50%+39.50% 43B
-2.10%+0.89%-48.99%-53.63% 40.94B
+0.12%-7.85%+48.39%-28.83% 29.4B
-10.83%-14.41%+102.94%-44.10% 27.09B
-1.53%-0.13%+70.16%+85.73% 23.32B
+3.88%+2.16%+11.36%+192.66% 19.89B
-1.59%-1.63%+64.87%+130.98% 16.91B
Average -1.38%-3.02%+38.22%+57.62% 35.53B
Weighted average by Cap. -1.36%-2.83%+31.31%+48.53%
Logo Iomai Corporation
Intercell USA, Inc. provides products for the delivery of vaccines to the skin through a proprietary technology known as transcutaneous immunization, or TCI. The Company is evaluating skin immunization techniques in several human clinical trials, including those to prevent influenza in the healthy adult and elderly populations, and also to prevent travelers' diarrhea and anthrax infection.
Employees
-